A single programmable RBC platform supports feeder-free T-cell activation and antigen-specific CAR-T cell expansion, with quantitatively controlled antigen presentation.
Authors: Andres Campos, Jinchun Wang, Ayomide Oloyede, Siddharth Subham, Noelle Lim, Javi Bravo-Alegria, Andries Zijlstra, Colleen M O’Connor
StimulusBio at Society of Immunotherapy in Cancer on November 6-7, 2026
in Phoenix, AZ
Contact StimulusBio to Talk About Your Scientific and Commercial Product Needs
In the competitive landscape of life science tools and diagnostics, even groundbreaking innovations struggle to gain traction and achieve widespread adoption. At StimulusBio, we specialize in empowering these vital technologies to reach their full potential. With our proven commercialization strategies and deep industry expertise, we partner with you at every stage to optimize your product’s marketability, reliability, and profitability – setting you up for lasting success in the marketplace.
